Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment is important for better hair regrowth in elderly women with hair loss.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Potassium levels affect blood sugar and insulin during dialysis, and malnutrition changes children's hair roots.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Gabapentin may cause hair loss in patients treated for neuropathic pain.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

A woman was misdiagnosed with hair loss for years, but actually had a rare type of alopecia.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

The trichoscopy-assisted hair pull test is useful for diagnosing different types of hair loss.

A girl with no hair neglect developed plica neuropathica in the hospital, lost all her hair, but it grew back.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Some patients experience temporary hair loss after ulcerative colitis surgery, likely due to illness rather than the surgery itself, and it usually grows back within six months.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

The new visual scale is a quick and effective way to measure hair loss in women.